William Blair Reaffirms Outperform Rating for Alto Neuroscience (NYSE:ANRO)
William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued on Friday morning,RTT News reports. William Blair also issued estimates for Alto Neuroscience’s Q1 2026 earnings at ($0.53) EPS, Q2 2026 earnings at ($0.53) EPS, Q3 2026 earnings at ($0.43) EPS and Q4 2026 earnings at […]
William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued on Friday morning,RTT News reports. William Blair also issued estimates for Alto Neuroscience’s Q1 2026 earnings at ($0.53) EPS, Q2 2026 earnings at ($0.53) EPS, Q3 2026 earnings at ($0.43) EPS and Q4 2026 earnings at […]
